These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 4316106

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of antilipolytic agents on dibutyryl cyclic AMP induced lipolysis in adipose tissue.
    Peterson MJ, Patterson C, Ashmore J.
    Life Sci; 1968 May 01; 7(9):551-60. PubMed ID: 4384996
    [No Abstract] [Full Text] [Related]

  • 9. The mechanism of action antilipolytic agents: a comparison of the effects of PGE1, insulin, tolbutamide, and phenformin on lipolysis induced by dibutryl cyclic AMP.
    Brown JD, Stone DB.
    Diabetes; 1968 May 01; 17():304-5. PubMed ID: 4297286
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibition of alpha-aminoisobutyric acid transport into isolated adipose tissue by N6,02'-dibutyryladenosine 3',5'-phosphate].
    v Bruchhausen F.
    Hoppe Seylers Z Physiol Chem; 1968 Oct 01; 349(10):1437-9. PubMed ID: 4301728
    [No Abstract] [Full Text] [Related]

  • 11. Demonstration that cyclic adenosine 3',5'-monophosphate mediates the lipolytic action of parathyroid hormone.
    Thajchayapong P, Queener SF, McClintock R, Allen DO, Bell NH.
    Horm Metab Res; 1976 May 01; 8(3):190-5. PubMed ID: 181304
    [Abstract] [Full Text] [Related]

  • 12. Catecholamines and metabolism of human adipose tissue. II. Effect of isoprophylnoradrenaline and adrenergic blocking agents on lipolysis in human omental adipose tissue in vitro.
    Ostman J, Efendić S.
    Acta Med Scand; 1970 Jun 01; 187(6):471-6. PubMed ID: 5458178
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of glucagon and adrenergic receptors in thyrocalcitonin release in the dog.
    Avioli LV, Shieber W, Kipnis DM.
    Endocrinology; 1971 Jun 01; 88(6):1337-40. PubMed ID: 4324677
    [No Abstract] [Full Text] [Related]

  • 15. Thyrotropin release in vitro: stimulation by cyclic 3',5'-Adenosine monophosphate.
    Wilber JF, Peake GT, Utiger RD.
    Endocrinology; 1969 Apr 01; 84(4):758-60. PubMed ID: 4304031
    [No Abstract] [Full Text] [Related]

  • 16. Influence of adrenal cortical hormones on the norepinephrine-induced lipolysis.
    Schönhöfer P, Skidmore IF, Bourne HR, Krishna GA, Brodie BB.
    Arzneimittelforschung; 1968 Dec 01; 18(12):1540-1. PubMed ID: 4304765
    [No Abstract] [Full Text] [Related]

  • 17. The effect of catecholamines and fasting on cyclic-AMP and release of glycerol from human adipose tissue.
    Gilbert CH, Galton DJ.
    Horm Metab Res; 1974 May 01; 6(3):229-33. PubMed ID: 4365558
    [No Abstract] [Full Text] [Related]

  • 18. Adenyl cyclase in human leukocytes: evidence for activation by separate beta adrenergic and prostaglandin receptors.
    Bourne HR, Melmon KL.
    J Pharmacol Exp Ther; 1971 Jul 01; 178(1):1-7. PubMed ID: 4325858
    [No Abstract] [Full Text] [Related]

  • 19. The effects of epinephrine, prostaglandins, and their antagonists on adenosine cyclic 3',5'-monophosphate concentrations and motility of the rat uterus.
    Vesin MF, Harbon S.
    Mol Pharmacol; 1974 May 01; 10(3):457-73. PubMed ID: 4369301
    [No Abstract] [Full Text] [Related]

  • 20. Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells.
    Manganiello VC, Murad F, Vaughan M.
    J Biol Chem; 1971 Apr 10; 246(7):2195-202. PubMed ID: 4324562
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.